Skip to main content
OpenTrials

Clinical trial condition

Non Muscle Invasive Bladder Cancer

Explore clinical trials studying Non Muscle Invasive Bladder Cancer. Study availability and eligibility vary by location and protocol.

23 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Non Muscle Invasive Bladder Cancer trial results

Active, not recruiting

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT04452591

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
Locations
  • Urology Centers Alabama Homewood, Alabama, United States
  • BCG Oncology Phoenix, Arizona, United States
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Arizona Institute of Urology Tucson, Arizona, United States
View all 86 locations
View Trial Details
Active, not recruiting

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

NCT06111235

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Urology Centers of Alabama PC Homewood, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arizona Institute of Urology PLLC Tucson, Arizona, United States
View all 95 locations
View Trial Details
Active, not recruiting

A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer

NCT06181266

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Michael G. Oefelein Clinical Trials Bakersfield, California, United States
  • Duke Health-Duke Cancer Center Durham, North Carolina, United States
  • Carolina Urologic Research Center, LLC Myrtle Beach, South Carolina, United States
  • Urology San Antonio Medical Center San Antonio, Texas, United States
View Trial Details
Completed

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

NCT05945108

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Research Site Belo Horizonte, Brazil
  • Research Site Porto Alegre, Brazil
  • Research Site Recife, Brazil
  • Research Site Salvador, Brazil
View Trial Details
Completed

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

NCT04387461

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • University of California - San Diego La Jolla, California, United States
  • University of California - Irvine Orange, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Tampa, Florida, United States
View all 19 locations
View Trial Details

Related conditions